A New Jersey jury recently awarded a substantial $1.59 million verdict to a victim who was prescribed the acne drug Accutane and developed Ulcerative Colitis. The jury found that Hoffman-LaRoche and Roche Laboratories, which manufactures Accutane “failed to provide Kamie Kendall Ries…with adequate warning of the health risks.” Ries’ winning…
Articles Posted in Defective Drugs
Judge Rules that $11 Million Topamax Birth Defect Award Will Stand
The $11 million ruling awarded by a jury in a Topamax birth defect case will stand, according to National Trial Lawyers. Court of Common Pleas Judge George W. Overton denied a motion by Johnson and Johnson subsidiary Janssen Pharmaceuticals for a new trial, upholding the original award for the family…
NECC Meningitis Victims Seek $100 Million Settlement
According to several sources, a judge has been asked to approve a $100 million settlement to aid victims of last year’s Meningitis outbreak, which was traced back to New England Compounding Center. The Massachusetts Pharmacy is believed to have manufactured steroid injections that were tainted with black mold and caused…
Multibillion-Dollar Lawsuits Adding up for Takeda Pharmaceuticals
A multibillion-dollar trial involving the drug Actos, manufactured by Takeda Pharmaceuticals, resumes today in a Las Vegas court. Actos is a single-ingredient drug used in conjunction with diet and exercise to help manage blood sugar levels in patients with type-2 diabetes. In the lawsuit, Bertha Triana, 80, and Delores Cipriano,…
Jury Issues $3M Topamax Injury Verdict Against Johnson & Johnson Unit
A jury says that Janssen Pharmaceuticals, a Johnson & Johnson unit, must pay $3 million for not warning a woman that using Topamax during pregnancy could cause birth defects. The plaintiffs contend that 5-year-old Payton Anderson was born with a cleft lip because her mother was prescribed the drug for…
Accutane Lawsuit Retrial Results in $1.5M Drug Defect Verdict
Jurors in a state court have awarded Kamie Kendall Rees $1,587,928 in her Accutane injury lawsuit against drug maker Hoffman La Roche Inc. The ruling comes in a retrial after an appeals court threw out the original verdict of $10.5 million on the grounds that a judge was improper in…
Indian Pharmaceutical Company Ranbaxy Under Fire Again After Latest Recall of Generic Lipitor
Indian drug maker Ranbaxy Laboratories Ltd. is facing harsh criticism after issuing a recall for more than 60,000 bottles of its generic cholesterol-lowering drug Lipitor. The recall was issued because of a dosage mix-up. A pharmacist discovered a 20-milligram tablet in a bottle marked for 10-milligram tablets. The company confirmed…
FDA Issues Warning to Males: Research Links Low-T Treatment to Increased Risk of Adverse Side Effects
Testosterone is a natural male hormone, and as men age their testosterone levels (t-levels) begin to decrease. Numerous factors can influence the decrease in testosterone levels, however low t-levels are often associated with medical conditions including testicular failure caused by genetic issues, cancer and chemotherapy. Testosterone therapy is often used…
Wyeth Must Face Defective Drug Label Claims Over Fen-Phen Diet Pill, Says Court
The Pennsylvania Supreme Court has ruled that drug maker Wyeth must deal with products liability claims alleging that the warning labels on a popular diet drug were defective. In a 4-2 vote in Lance v. Wyeth, the majority rejected the claim that inadequate warnings and manufacturing defects are the only…
Fosamax Update: Femur Fracture Plaintiffs Go To Trial & Merck Agrees to Proposed $27.7M Settlement Over ONJ Lawsuits
The next trial over a Fosamax femur fracture claim will start in May as part of Multidistrict Litigation in district court in New Jersey. Meantime, the drug’s manufacturer, Merck & Co., has agreed to a proposed $27.7 million to settle ONJ lawsuits filed by plaintiffs who say that the bisphosphonate…